Governance Neutral

2026-09-28 18:45

- Ms. Purana Housdurgam Vijayadeepti retired as Non-Executive Independent Director effective September 28, 2026, upon completion of her term. - Mrs. Neela Bhattacherjee was appointed as Non-Executive Independent Director for a 3-year term effective September 28, 2026. - Reconstitution of board committees was announced following the retirement and new appointment.

Governance Neutral

2026-09-28 18:40

- Ms. Purana Housdurgam Vijayadeepti retired as Non-Executive Independent Director effective 28 September 2026 upon completion of her term. - Ms. Neela Bhattacherjee was appointed as an Additional Director in the category of Non-Executive Independent Director for a term of three years effective 28 September 2026. - Changes were made to committee memberships and chairmanships, including Mr. Neeraj Jain becoming Chairman of the Risk Management Committee.

Routine Neutral

2026-09-26 20:11

- Trading window for dealing in company securities will remain closed starting 1 October 2026. - Closure applies to all Designated Persons and their immediate relatives. - Reopens 48 hours after declaration of Q2/H1 FY27 unaudited financial results.

Governance Neutral

2026-09-26 20:05

Aster DM Quality Care Limited submitted voting results and scrutinizer's report for the Postal Ballot concluded on September 25, 2026. - All 8 resolutions, including appointments of directors, managing director, and revisions in managerial remuneration, were passed with the requisite majority.

Business Update Positive

2026-09-16 15:39

- ICRA has upgraded the long-term credit rating of KIMS Healthcare Management Limited, a material subsidiary of Aster DM Quality Care Limited, to [ICRA]AA (Stable) from [ICRA]AA-. - Short-term ratings have been reaffirmed at [ICRA]A1+. - The ratings for facilities totaling ₹210 crore have been removed from Rating Watch with Developing Implications and assigned a Stable outlook.

Routine Neutral

2026-09-05 11:26

- Aster DM Quality Care Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, as per SEBI Regulation 34(2)(f). The report, assured by BDO India Services Private Limited, forms part of the Integrated Annual Report for FY 2024-25 and is available on the company's website.

Ownership Positive

2026-09-04 12:14

- Dr. Moopen family (promoter group) acquired an additional 0.57% stake in Aster DM Quality Care, purchasing 46.09 lakh shares for ₹350.34 crore at ₹760/share on September 2, 2026. - This increases their total shareholding to 24.58%, reinforcing commitment to the company's long-term growth.

Business Update Positive

2026-08-31 22:20

- Capacity expansion approved for KIMSHEALTH Hospital, Trivandrum, adding ~184 beds. - Total capacity post-expansion will be ~979 beds. - Investment of ₹134.4 crore, financed 70% debt and 30% equity, expected by May 2028.

Business Update Positive

2026-08-29 18:40

- Approval of Scheme of Amalgamation for two step-down subsidiaries, KIMSHEALTH Executive Leisure Private Limited (KEL) and Spiceretreat Hospitality Services Private Limited (SHSPL), effective April 1, 2026. - Aims to simplify group structure and enhance operational efficiencies. No change in listed entity's shareholding.

Business Update Positive

2026-08-28 18:27

- Aster DM Quality Care Limited's subsidiary acquired a 14.21% stake in STS Holdings Limited, a Bangladesh-based healthcare company, for USD 44,114,339. The acquisition aligns with a Merger Framework Agreement and enhances business in healthcare services. STS Holdings Limited reported a turnover of BDT 10,534.24 Million for the year ended 31 March 2026.

Governance Positive

2026-08-26 21:26

- Postal Ballot Notice for shareholder approval of governance changes. - Key proposals: Appointment of new MD & Group CEO Mr. Varun Shadilal Khanna, six other Non-Executive/Independent Directors, revised remuneration for Executive Chairman & Executive Director, and approval of Aster DM Quality Care Limited Employee Stock Option Scheme 2026.

Business Update Neutral

2026-08-14 18:36

- Trading approval received for 35,35,51,410 Equity Shares of ₹10/- each, allotted pursuant to the Scheme of Amalgamation. - These shares will be listed and available for trading on BSE and NSE from August 17, 2026.

Financials Positive

2026-08-12 14:44

- Q1 FY27 Consolidated Proforma Revenue ₹2,597Cr vs ₹2,164Cr (▲20% YoY) - EBITDA ₹576Cr vs ₹443Cr (▲30% YoY) - EBITDA Margin 22.2% vs 20.5% (▲170bps) - Management targets 24-25% EBITDA margin in the next 2-3 years and anticipates 10-15% incremental EBITDA from merger synergies. - Plans to add over 4,170 beds in the next 3-4 years, increasing total capacity to over 15,000 beds.

Business Update Neutral

2026-08-05 23:02

- Video/Audio recording of the earnings call for the quarter ended June 30, 2026, held on August 5, 2026, is available on Aster DM Quality Care Limited's website.

Business Update Neutral

2026-08-05 22:40

- Analyst/Investors Meet Schedule - Event: Non-deal Roadshow organized by Kotak Mahindra Capital Company Limited - Date: 10th August 2026 to 14th August 2026 - Time: Business hours (9:00 AM to 6 PM IST/SGT) - Mode: Virtual and In-Person (Mumbai and Singapore)

Business Update Neutral

2026-08-05 20:02

- Board meeting on 05 August 2026 approved the Notice of Postal Ballot and 18th Annual General Meeting (scheduled for 28 September 2026). - Termination of operations and management agreement for Aster G. Madegowda Hospital due to sustained operating losses (0.15% of revenue). - Acquisition of up to an additional 12% equity stake in subsidiary United CIIGMA Institute of Medical Sciences Private Limited (UCIMSPL) for up to ₹40.93 crores.

Business Update Neutral

2026-08-05 19:56

- Board approved terminating operations for Aster G. Madegowda Hospital due to sustained losses (0.15% of revenue). - Approved acquiring up to 12% additional stake in subsidiary United CIIGMA Institute of Medical Sciences for up to ₹40.93 Cr. - Also approved Postal Ballot and 18th AGM on 28 September 2026.

Financials Positive

2026-08-05 17:39

- Consolidated Revenue ₹2,597 Cr (▲20% YoY) - EBITDA ₹576 Cr (▲30% YoY) - EBITDA Margin 22.2% vs 20.5% (▲170bps)

Financials Neutral

2026-08-05 17:27

- Consolidated Revenue ₹1,310.68 Cr vs ₹1,077.87 Cr (▲21.60% YoY) - EBITDA ₹141.55 Cr vs ₹197.25 Cr (▼28.24% YoY) - PAT ₹29.28 Cr vs ₹93.56 Cr (▼68.71% YoY) - EBITDA Margin 10.80% vs 18.30% (▼750 bps) - The quarter included an exceptional expense of ₹114.38 Cr related to merger costs. Profit before exceptional items and tax grew by 37.05% YoY to ₹200.85 Cr.

ASTERDM

Aster DM Healthcare Limited

Price Chart

Filing History

Unlock Full History